Contribution to the Global Health Innovative Technology Fund (GHIT Fund) Leave a comment
The Global Health Innovative Technology Fund (GHIT Fund) is an international public-private fund in which the Japanese government (Ministry of Foreign Affairs, Ministry of Health, Labor and Welfare), private companies such as pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome Trust, and the United Nations Development Program participate. GHIT Fund has been investing in new drug development and portfolio management to contribute to global health, supporting Japanese technology and innovation to combat infectious diseases such as malaria, tuberculosis, and neglected tropical diseases (NTDs) that affect the world’s vulnerable and underserved populations. GHIT Fund promotes the participation of Japanese pharmaceutical companies, universities, and research institutes in product development, as well as collaboration with overseas institutions, in order to develop drugs, vaccines, and diagnostics.
For more information, please visit https://www.ghitfund.org/en
